Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
Utilizing Spheres of Influence to Increase Cancer Screening: Empowering Community Health Advocates
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 40 Years to 80 Years
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Time periods mentioned: 3 years
- Procedures mentioned: CT scans, Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "Lung screening with computed tomography scans is poorly used, despite the potential to decrease deaths from lung cancer."
- "Identify knowledge base and psychological barriers to screening through surveys of potential screening participants."
- "After completion of study intervention, participants are followed up yearly for up to 3 years."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether people who support breast and lung cancer screening can help more eligible people get lung screening. It also looks at fears and other feelings that may keep people from getting screened. It is for people in the listed age groups who have a close friend or family member with a history of smoking.
This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Imaging-based cancer screening is utilized with variable frequency. Breast cancer screening with mammography has been widely accepted and is commonly used among eligible women. Lung screening with computed tomography scans is poorly used, despite the potential to decrease deaths from lung cancer. There are many reasons lung screening isn't being used when compared to breast screening, such as smoking stigma and fear, along with a lack of awareness of lung screening. By conducting this trial, researchers want to assess the effectiveness of advocates and supporters of breast and lung screening, and to learn about the psychological barriers to cancer screening, identifying those that are unique to lung screening.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- For breast screening: older than 40.
- For lung screening: ages 50 to 80.
- Male or female.
- People who smoke now, used to smoke, or have never smoked.
- Have a close friend or family member who smokes or used to smoke, in any state.
Who can't join
- For breast screening: younger than 40.
- For lung screening: younger than 50 or older than 80.
- Have been diagnosed with lung cancer in the past.
- Have coughed up blood.
- Lost more than 15 pounds in the past year without a known reason.
- Have cancer now.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Age: * Breast screening \> 40 * Lung screening 50-80 * Male (M) or Female (F) * Current, former, or never smokers * Close family or friend with smoking history (in or out of state) Exclusion Criteria: * Age: * Breast screening \< 40 * Lung screening \< 50 or \> 80 * Persons who had previously received a diagnosis of lung cancer, had hemoptysis, or had an unexplained weight loss of more than 6.8 kg (15 lb) in the preceding year will also be excluded * Persons with an active cancer
Study sites (1)
CA
- UCLA / Jonsson Comprehensive Cancer Center · Los Angeles, CA 90095Ashley E. Prosper · Study contact · 310-825-0958 · APROSPER@MEDNET.UCLA.EDUAshley E. Prosper · Principal investigatorMore trials in Los Angeles